Adult Attention Deficit Hyperactivity Disorder Clinical Trial
— OCEAN-GEROfficial title:
The Relationship of Essential Fatty Acids to Cognitive, Electrophysiological and Behavioural Function in Adults With Attention Deficit Hyperactivity Disorder and Controls
Verified date | October 2020 |
Source | Saarland University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The aim of this project is to investigate the effect of a dietary supplementation with essential fatty acids in adults on cognitive functions related to attention and impulse control in the general population and in individuals with a diagnosis of attention deficit hyperactivity disorder (ADHD).
Status | Completed |
Enrollment | 100 |
Est. completion date | December 2015 |
Est. primary completion date | December 2014 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 60 Years |
Eligibility | Inclusion Criteria: - DSM-IV ADHD Exclusion Criteria: - any acute psychiatric disorder |
Country | Name | City | State |
---|---|---|---|
Germany | Saarland University Hospital | Homburg/Saar | Saarland |
Lead Sponsor | Collaborator |
---|---|
Saarland University |
Germany,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Cued continous performance test - QB-version | Motorhyper activity, concentration and impulsivity in adult ADHD patients | 6 months | |
Primary | Wender Reimherr Adult Attention Deficit Disorder Scale (WRAADDS) | Psychopatholoy of adult ADHD | 6 months | |
Secondary | Short and long interval cortical inhibition (SICI and LICI) | Motoric evoced potentials by transcranial magnetic stimulation (TMS) | 6 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06000501 -
Duration and Efficacy of Azstarys on Adult ADHD Symptoms and Executive Function in Early Evening
|
Phase 4 | |
Completed |
NCT03721588 -
Clinical and Suicidal Features of Urban, Turkish Middle Age Depressive Patients With Comorbid ADHD
|
||
Completed |
NCT03324581 -
The Safety and Efficacy of OPC-64005 in the Treatment of Adult Attention-deficit/Hyperactivity Disorder
|
Phase 2 | |
Active, not recruiting |
NCT06221930 -
Researching the Effectiveness of Attexis, a Digital Health Application for Adults With Attention Deficit Hyperactivity Disorder
|
N/A | |
Completed |
NCT02160262 -
Open-label Safety Study in Adults With ADHD
|
Phase 3 | |
Completed |
NCT02276209 -
Dasotraline Adult ADHD Study
|
Phase 3 | |
Completed |
NCT01692782 -
Adult Attention Deficit Hyperactivity Disorder
|
Phase 2 | |
Completed |
NCT00553319 -
Study of Adderall-XR for the Treatment of Adult Attention Deficit Hyperactivity Disorder and Cocaine Dependence
|
Phase 2/Phase 3 |